• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Cognitive Disorders  • Dementias  • Neurogenetics  • Diagnosis  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Brendan J. Kelley, MD; Wael Haidar, MD; Bradley F. Boeve, MD; Matt Baker, BSc; Maria Shiung, BA; David S. Knopman, MD; Rosa Rademakers, PhD; Mike Hutton, PhD; Jennifer Adamson, BS; Karen M. Kuntz, RN; Dennis W. Dickson, MD; Joseph E. Parisi, MD; Glenn E. Smith, PhD; Ronald C. Petersen, PhD, MD

Arch Neurol. 2010;67(2):171-177.

Objective  To characterize a kindred with a familial neurodegenerative disorder associated with a mutation in progranulin (PGRN), with emphasis on the unique clinical features in this kindred.

Design  Antemortem and postmortem characterization of a kindred with a familial neurodegenerative disorder.

Setting  Multispecialty group academic medical center.

Patients  Affected members of a kindred with dementia with or without parkinsonism associated with a unique mutation in PGRN.

Main Outcome Measure  Genotype-phenotype correlation.

Results  Of 10 affected individuals identified, 6 presented with early amnestic symptoms which resulted in initial diagnoses of Alzheimer disease or amnestic mild cognitive impairment. Some individuals presented with features characteristic of frontotemporal dementia. Mean age at onset was substantially younger in generation III (75.8 years; range, 69-80 years) than in generation II (60.7 years; range, 55-66 years). The pattern of cerebral atrophy varied widely in the affected individuals. Neuropathologic features in 6 individuals included frontotemporal lobar degeneration with ubiquitin-positive neuronal cytoplasmic and intranuclear inclusions (FTLD-U with NII). PGRN analysis revealed a single base pair deletion in exon 2 (c.154delA), which caused a frameshift (p.Thr52HisfsX2) and, therefore, creation of a premature termination codon and a likely null allele.

Conclusions  In this large kindred, most affected individuals had clinical presentations that resembled Alzheimer disease or amnestic mild cognitive impairment associated with a mutation in PGRN and underlying FTLD-U with NII neuropathologic abnormalities. This finding is in distinct contrast to previously reported kindreds, in which clinical presentations have typically been within the spectrum of FTLD. The basis for the large difference in age at onset between generations requires further study.

Author Affiliations: Departments of Neurology (Drs Kelley, Haidar, Boeve, Knopman, and Petersen, and Ms. Kuntz), Radiology (Ms Shiung), Laboratory Medicine and Pathology (Dr Parisi), Psychiatry and Psychology (Dr Smith), and Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation (Drs Kelley, Haidar, Boeve, Knopman, Smith, and Petersen), Mayo Clinic, Rochester, Minnesota; Neurogenetics Laboratory (Drs Hutton and Rademakers, Mr Baker, and Ms Adamson) and Neuropathology Laboratory (Dr Dickson), Mayo Clinic, Jacksonville, Florida.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2010;67(2):143-144.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration
Rohrer et al.
Brain 2011;134:2565-2581.
ABSTRACT | FULL TEXT  

An algorithm for genetic testing of frontotemporal lobar degeneration
Goldman et al.
Neurology 2011;76:475-483.
ABSTRACT | FULL TEXT